Is rTMS Ready for Primetime?

The authors explore the growing interest in the use of repetitive transcranial magnetic stimulation (rTMS) for the treatment of major depressive disorder (MDD). Topics discussed include the studies which investigated the effectiveness of RTMS in individuals with treatment-resistant depression (TRD), the medical device approval earned by rTMS from the U.S. Food and Drug Administration (FDA), and the need to acknowledge the neurobiological and clinical complexity of MDD in its treatment.